Fields of application

TauroLock™ is recommended for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.

TauroLock™-U25.000 ensures a particularly strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU urokinase.

TauroLock™-Hep100 is suitable for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and maintain a high patency rate.

TauroLock™-HEP500 has been developed specifically for dialysis patients. It prevents catheter-related infections and occlusions.

NutriLock™ is a heparin-free and citrate-free lock solution. Based on the antimicrobial agent taurolidine, it protects patients against catheter-related infections.